PrimeRFP SCOUT · Federal Contract Recompete Brief

75N93026C00012Develop a therapeutic SMALL molecule VIRAL — Arisan Therapeutics Inc

Arisan Therapeutics Inc holds $3.7M across 3 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award in the incumbent pipeline. Competition previously drew 20 offers. Set-aside status: NONE. Recompete timing centers on the Jun 30, 2027 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health Niaid

Awarding office

Arisan Therapeutics Inc

Recipient

Jun 30, 2027

PoP end

$2.9M

Obligated

$23.9M

Potential

541715

NAICS

AN12

PSC

NONE

Set-aside

20 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Arisan Therapeutics Inc — $90

Contract facts

NONE

Contract number75N93026C00012

AgencyNational Institutes Of Health Niaid

Awarding officeNational Institutes Of Health Niaid

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentArisan Therapeutics Inc

CAGE616D2

UEIPYRKTQPNVJZ8

NAICS541715

PSCAN12

Place of performanceCARLSBAD CA

Pricing typeCost Plus Fixed Fee

Extent competedFull And Open Competition

Related solicitationHHS-NIH-NIAID-BAA2025-1

PoP startAug 3, 2026

PoP end (current)Jun 30, 2027

Obligated$2.9M

Current value$2.9M

Potential value$23.9M

TO DEVELOP A THERAPEUTIC SMALL MOLECULE VIRAL ENTRY INHIBITOR AS A MEDICAL COUNTERMEASURE FOR FILOVIRUS INFECTION. is a federal NONE award for National Institutes Of Health Niaid held by Arisan Therapeutics Inc. Estimated value $23.9M ($2.9M obligated). Current period of performance ends Jun 30, 2027. Last award drew 20 bidders. Place of performance: CARLSBAD CA. Related solicitation HHS-NIH-NIAID-BAA2025-1.

TO DEVELOP A THERAPEUTIC SMALL MOLECULE VIRAL ENTRY INHIBITOR AS A MEDICAL COUNTERMEASURE FOR FILOVIRUS INFECTION.

Recompete timing

Public

● Expiring in 296 days

Current PoP ends Jun 30, 2027 (296 days remaining). Agencies typically plan 12–18 months ahead — at 9.7 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Arisan Therapeutics Inc — $3.7M obligated across 3 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$3.7M · 100% of firm total

Open full company profile →

Related awards

Same incumbent

75N93023C00051

TO CONDUCT NON-CLINICAL GOOD LABORATORY PRACTICE (GLP) IN VIVO GENOTOXICITY AND REPRODUCTI…

$3.7M

Dec 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N93026C00012?

75N93026C00012 (Develop a therapeutic SMALL molecule VIRAL) is a National Institutes Of Health Niaid award with a potential value of $23.9M, currently held by Arisan Therapeutics Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N93026C00012?

National Institutes Of Health Niaid awarded 75N93026C00012 to Arisan Therapeutics Inc (potential $23.9M).

Who is the incumbent on 75N93026C00012?

Arisan Therapeutics Inc is the incumbent with $3.7M across 3 related awards in SCOUT’s public footprint. The current period of performance ends Jun 30, 2027.

When does Arisan Therapeutics Inc’s 75N93026C00012 come up for recompete?

SCOUT tracks a period-of-performance end of Jun 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N93026C00012 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Jul 29, 2026